Emotional Disorders in Chronic Medical Illness

  • Earl A. BurchJr.

Abstract

The percentage of people over age 65 is growing at a rapid rate and is expected to double over the next 50 years (Burch, 1985). Currently, 12% of the U.S. population is older than 65, but in 40 years it is estimated that one in five Americans will survive to this age (Burch, 1985). This demographic shift will challenge health care providers to diagnose and treat the accompanying change in mental health needs of the aging population.

Keywords

Lithium Migraine Digoxin Clozapine Clonidine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adams, E, Fernandez, F, & Anderson, B. S. (1986). Emergency pharmacotherapy of delirium in the critically ill cancer patient. Psychosomatics, 27, 33–37.PubMedCrossRefGoogle Scholar
  2. Anthony, J. C., Lesche, L., Niaz, U., Von Korff, M. R., & Folstein, M. F (1982). Limits of the “mini-mental state” as a screening test for dementia and delirium among hospital patients. Psychological Medicine, 12, 397–408.PubMedCrossRefGoogle Scholar
  3. Anton, R. F, Hitri, A., Diamond, B. I., & Shelhorse, M. (1986). Amoxapine treatment of psychotic depression: Dose effect and dopamine blockade [Monograph]. Journal of Clinical Psychiatry, 4(2), 32–36.Google Scholar
  4. Ayd, F. J. (Ed.). (1988). Psychopharmacotherapy for HIV infected, AIDS-related complex (ARC), and AIDS patients. International Drug Therapy Newsletter, 23(6). Google Scholar
  5. Baldessarini, R. J. (1985). Chemotherapy in psychiatry (2nd ed.). Cambridge, MA: Harvard University Press.Google Scholar
  6. Barrett, J. E., Barrett, J. A., Oxman, T. E., & Gerber, R D. (1988) The prevalence of psychiatric disorders in a primary care practice. Archives of General Psychiatry, 45, 1100–1106.PubMedCrossRefGoogle Scholar
  7. Beck, A. T. (1967). Depression: Clinical, experimental and theoretical aspects. New York: Hoeber.Google Scholar
  8. Blackwell, B. (1987). Newer antidepressants. In H. Y. Meltzer (Ed.), Psychopharmacology: The third generation of progress. (pp. 1041–1049). New York: Raven.Google Scholar
  9. Bouckams, A. J. (1981). Analgesic adjuvants: The role of psychotropics, anticonvulsants, and prostaglandin inhibitors. Drug Therapy, 6, 41–48.Google Scholar
  10. Burch, E. A., Jr. (1985). Psychopharmacological variables in the elderly [Monograph]. Philadelphia: Wyeth Laboratories.Google Scholar
  11. Burch, E. A., Jr. (1990). Use and misuse of benzodiazepines in the elderly. Psychiatric Medicine, 8, 98–105.Google Scholar
  12. Burch, E. A., Jr., & Brandenburg, J. H. (1990). Variables contributing to distress in male cardiac patients. The Journal of Family Practice, 30(1), 43–48.PubMedGoogle Scholar
  13. Burch, E. A., & Montoya, J. (1989). Neuroleptic malignant syndrome in an AIDS patient [Letter to the editor]. Journal of Clinical Psychopharmacology, 9, 228–229.PubMedCrossRefGoogle Scholar
  14. Burch, E. A., Jr., & Sitzman, B. T. (1990). Anxiety and distress in male cardiac patients: Diagnostic and treatment guidelines. American Journal of Preventive Psychiatry and Neurology, 2, 12–16.Google Scholar
  15. Butcher, J. N., Graham, J. R., Williams, C. L., & Ben-Porath, Y. (1989) Innovations in MMPI-2 interpretation: Development and use of the MMPI-2 content scales. Minneapolis: University of Minnesota Press.Google Scholar
  16. Cavanaugh, S. V. A. (1984). Diagnosing depression in the hospitalized patient with chronic medical illness. Journal of Clinical Psychiatry, 45, 13–16.PubMedGoogle Scholar
  17. Cavanaugh, S. V. A., Clark, D. C., & Gibbons, R. D. (1983). Diagnosing depression in the hospitalized medically ill. Psychosomatics, 24, 809–815.PubMedCrossRefGoogle Scholar
  18. Chiarello, N., & Burch, E. A., Jr. (1989). Recognition and treatment of psychiatric disorders in the hospitalized medically ill elderly [Abstract]. Southern Medical Journal, 82, 138.Google Scholar
  19. Clancy, J., & Noyes, R. (1976). Anxiety neurosis: A disease for the medical model. Psychosomatics, 17, 90–93.PubMedGoogle Scholar
  20. Cohen, L. S., Heller, V. L., & Rosenbaum, J. F. (1989). Treatment guidelines for psychotropic drug use in pregnancy. Psychosomatics, 30, 25–33.PubMedCrossRefGoogle Scholar
  21. Craven, J. L., Rodin, G. M., Johnson, L., & Kennedy, S. H. (1987). The diagnosis of major depression in renal dialysis patients. Psychosomatic Medicine, 49, 482–492.PubMedGoogle Scholar
  22. Davidson, J. (1989). Seizures and buproprion: A review. Journal of Clinical Psychiatry, 50, 256–261.PubMedGoogle Scholar
  23. Daulo, J. R. & Folstein, M. E (1978). Psychiatric disturbances in neurological patients: Detection, recognition, and hospital course. Annals of Neurology, 4, 225–228.CrossRefGoogle Scholar
  24. Fernandez, F, & Ruiz, P (1989). Psychiatric aspects of HIV disease. Southern Medical Journal, 82, 999–1004.PubMedCrossRefGoogle Scholar
  25. Folks, D. G., & Ford, C. V. (1985). Psychiatric disorders in geriatric medical/surgical patients. Part I: Report of 195 consecutive consultations. Southern Medical Journal, 78, 239–241.PubMedCrossRefGoogle Scholar
  26. Folstein, M. F, Folstein, S. E., & Mugh, P R. (1975). “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189–198.PubMedCrossRefGoogle Scholar
  27. Gabuzda, D H, & Hirsch, M. S. (1987) Neurologicjnanifestations of infection with human immunodeficiency virus: Clinical features and pathogenesis. Annals of Internal Medicine, 107, 383–391.PubMedGoogle Scholar
  28. Gelenberg, A. J. (Ed.). (1989). Carbamazepine teratogenesis. Biological therapies in psychiatry (Vol. 12, no. 9). Littleton, MA: Year Book Medical.Google Scholar
  29. Glassman, R., & Salzman, C. (1987). Interactions between psychotropic and other drugs: An update. Hospital and Community Psychiatry, 38, 236–243.PubMedGoogle Scholar
  30. Gould, R. J., Murphey, K. M. M., Reynolds, I. J., & Snyder, S. H. (1983). Antischizophrenic drugs of the diphenylbutylpiperidine type act as calcium channel antagonists. Proceedings of the National Academy of Sciences, 80, 5122–5125.CrossRefGoogle Scholar
  31. Green, R. L., Mllister, T. W., & Bernat, J. L. (1987). A study of crying in medically and surgically hospitalized patients. American Journal of Psychiatry, 144, 442–447.PubMedGoogle Scholar
  32. Greenblat, D. J., Sellers, E. M., & Shader, R. I. (1982). Drug disposition in old age. New England Journal of Medicine, 306, 1081–1088.CrossRefGoogle Scholar
  33. Groves, J. E., & Kucharski, A. (1987). Brief psychotherapy. In T. P Hackett & N. H. Cassem (Eds.), Handbook of general hospital psychiatry (2nd ed., pp. 309–331). Littleton, MA: PSG.Google Scholar
  34. Hamilton, M. (1959). The assessment of anxiety states by rating. British Journal of Medical Psychology, 32, 50–55.PubMedCrossRefGoogle Scholar
  35. Henningsen, N. C., & Mattiasson, I. (1979). Long-term clinical experience with atenolol—a new selective beta-1-blocker with few side effects from the central nervous system. Acta Medica Scandinavica, 205, 61–66.PubMedCrossRefGoogle Scholar
  36. Henrichs, T. F. (1981). Using the MMPI in medical consultation. In J. Butcher, G. Dahlstrom, M. Gynther, & W. Schofield (Eds.), Clinical notes on the MMPI. Minneapolis: National Computer Systems.Google Scholar
  37. Holmes, V. F., Fernandez, F., & Levy, J. K. (1989). Psychostimulant response in AIDS-related complex patients. Journal of Clinical Psychiatry, 50, 5–7.PubMedGoogle Scholar
  38. Jefferson, J. W., Greist, J. H., Ackerman, D. L., & Carroll, J. A. (1987). Lithium encyclopedia for clinical practice (2nd ed.). Washington, DC: American Psychiatric Press.Google Scholar
  39. Jones, J. B., Barklage, N. E., & Jefferson, J. W. (1989). Non-psychiatric uses of antidepressants: Part I: Chronic pain and migraine. Hospital Therapy, 14, 24–32.Google Scholar
  40. Knights, E. B., & Folstein, M. E (1977). Unsuspected emotional and cognitive disturbances in medical patients. Annals of Internal Medicine, 87, 723–724.PubMedGoogle Scholar
  41. Lipowski, Z. J. (1967). Review of consultation psychiatry and psychosomatic medicine: II. Clinical aspects. Psychosomatic Medicine, 29, 201–244.PubMedGoogle Scholar
  42. Lipowski, Z. J. (1977). Psychiatric consultation: Concepts and controversies. American Journal of Psychiatry, 134, 523–528.PubMedGoogle Scholar
  43. Lipsey, J. R., Robinson, R. G., Pearlson, G. D., Rao, K, & Price, T. R. (1984). Nortriptyline for post-stroke depression: A double blind study. Lancet, 1, 297–300.PubMedCrossRefGoogle Scholar
  44. Lipsey, J. R., Spencer, W. C., Rabins, P V., & Robinson, R. G. (1986). Phenomenological comparison of poststroke depression and functional depression. American Journal of Psychiatry, 143, 527–529.PubMedGoogle Scholar
  45. Marsland, D. W, Wood, M., & Mayo, F (1976). Content of family practice: A data bank for patient care curriculum and research in family practice; 526,196 patient problems. Journal of Family Practice, 3, 25–68.PubMedGoogle Scholar
  46. Mellinger, G. D., Baiter, M. B., & Uhlenhuth, E. H. (1984). Prevalence and correlates of the long-term regular use of anxiolytics. Journal of the American Medical Association, 251, 375–379.PubMedCrossRefGoogle Scholar
  47. Moffic, H. S., & Paykel, E. S. (1975). Depression in medical in-patients. British Journal of Psychiatry, 126, 346–353.PubMedCrossRefGoogle Scholar
  48. Mosbacher, R. A., Ortner, R., Kincannon, C. L. (1989). Statistical Abstract of the United States 1989. Washington, DC: Government Printing Office.Google Scholar
  49. Ostrow, D., Grant, I., & Atkinson, H. (1988). Assessment and management of the AIDS patient with neuropsychiatric disturbances [Supplement]. Journal of Clinical Psychiatry, 49(5), 14–22.PubMedGoogle Scholar
  50. Owen, R. R., & Cole, J. O. (1989). Molindone hydrochloride: A review of laboratory and clinical findings. Journal of Clinical Psychopharmacology, 9, 268–276.PubMedCrossRefGoogle Scholar
  51. Port, F. K. (1979). Lithium in hemodialysis. Psychosomatics, 20, 130–131.PubMedGoogle Scholar
  52. Post, R. M. (1989). Introduction: emerging perspectives on valproate in affective disorders [Supplement]. Journal of Clinical Psychiatry, 50(3), 3–9.PubMedGoogle Scholar
  53. Rap, S. R., & Vrana, S. (1989). Substituting nonsomatic for somatic symptoms in the diagnosis of depression in elderly male medical patients. American Journal of Psychiatry, 146, 1197–1200.Google Scholar
  54. Reich, P., & Kelly, M. J. (1976). Suicide attempts by hospitalized medical and surgical patients. New England Journal of Medicine, 294, 298–301.PubMedCrossRefGoogle Scholar
  55. Rickels, K, Chung, H. R., Csanalosi, I. B., Hurowitz, A. M., London, J., Wiseman, K, Kaplan, M., & Amsterdam, J. D. (1987) Alprazolam, diazepam, imipramine, and placebo in outpatients with major depression. Archives of General Psychiatry, 44, 862–866.PubMedCrossRefGoogle Scholar
  56. Robins, L. N., Helzer, J. E., Croughan, J., Williams, J. B. W., Spitzer, R. L. (1981). The NIMH Diagnostic Interview Schedule: Version III (DHHS Publication ADM T-42–3). Washington, DC: Government Printing Office.Google Scholar
  57. Roose, S. P, & Glassman, A. H. (1989). Cardiovascular effects of tricyclic antidepressants in depressed patients with and without heart disease [Monograph]. Journal of Clinical Psychiatry, 7(2), 1–18.Google Scholar
  58. Rosenbloom, A. (1988). Emerging treatment options in the alcohol withdrawal syndrome [Supplement]. Journal of Clinical Psychiatry, 49(12), 28–31.PubMedGoogle Scholar
  59. Rosenman, R. H. (1985). The impact of anxiety on the cardiovascular system. Psychosomatics, 26(Suppl.), 6–15.PubMedGoogle Scholar
  60. Rozanski, A., Bairey, C. N., Krantz, D. S., Friedman, J., Resser, K. J., Morell, M., Hilton-Chalfen, S., Hestrin, L., Bietendorf, J., & Berman, D. S. (1988). Mental stress and the induction of silent myocardial ischemia in patients with coronary artery disease. New England Journal of Medicine, 318, 1005–1012.PubMedCrossRefGoogle Scholar
  61. Schwab, J. J., Muinness, N. H., & Marder, L. (1966). Evaluating anxiety in medical patients. Journal of Chronic Disease, 19, 1049–1057.CrossRefGoogle Scholar
  62. Schwab, J. J., Traven, N. D., & Warheit, G. J. (1978). Relationships between physical and mental illness. Psychosomatics, 19, 458–463.PubMedGoogle Scholar
  63. Sher, M., Krieger, J. N., & Juergens, S. (1983). Trazodone and priapism. American Journal of Psychiatry, 140, 1362–1363.Google Scholar
  64. Stern, T. A., Caplan, R. A., & Cassem, N. H. (1987). Use of benzodiazepines in a coronary care unit. Psychosomatics, 28, 19–23.PubMedCrossRefGoogle Scholar
  65. Strain, J. J., & Grossman, S. (1975). Psychological care of the medically ill: a primer in liaison psychiatry. New York: Appleton-Century-Crofts.Google Scholar
  66. Stratton, J. R., & Halter, J. B. (1985). Effect of a benzodiazepine (alprazolam) on plasma epinephrine and norepinephrine levels during exercise stress. American Journal of Cardiology, 56, 136–139.PubMedCrossRefGoogle Scholar
  67. Swenson, W., Pearson, J., & Osborne, D. (1973). An MMPI source book. Minneapolis: University of Minnesota Press.Google Scholar
  68. Thompson, T. L., Moran, M. G., & Nies, A. S. (1981). Psychotropic drug use in the elderly. New England Journal of Medicine, 308, 134–138.Google Scholar
  69. Uhlenhuth, E. H., Dit, H., Balter, M. B., Johanson, C. E., & Mellinger, G. D. (1988). Risks and benefits of long-term benzodiazepine use. Journal of Clinical Psychopharmacology, 8, 161–167.PubMedCrossRefGoogle Scholar
  70. Wallack, J. J. (1989). AIDS anxiety among health care professionals. Hospital and Community Psychiatry, 40, 507–510.PubMedGoogle Scholar
  71. Weilberg, J. B. (1983). Temporal lobe epilepsy. In E. L. Bassuk, S. C. Schoonover, & A. T. Gelenberg (Eds.), The practitioner’s guide to psychoactive drugs (2nd ed., pp. 373–398). New York: Plenum Medical.CrossRefGoogle Scholar
  72. Wells, K. B., Golding, J. M., & Burnam, M. A. (1988). Psychiatric disorder and limitations in physical functioning of the Los Angeles general population. American Journal of Psychiatry, 145, 712–717.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1993

Authors and Affiliations

  • Earl A. BurchJr.
    • 1
  1. 1.Department of Veterans Affairs Medical CenterUniversity of Utah School of MedicineSalt Lake CityUSA

Personalised recommendations